SCHEMBL29946201

SCHEMBL29946201

O=C(O)Cc1cccc(-c2cn(-c3ccc(-c4ccc5c(c4)OCCO5)cc3)nn2)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STIM1 Q13586 5/20 0.75
ORAI1 Q96D31 5/20 0.75
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47
NOTUM Q6P988 1/20 0.44
OGT O15294 2/20 0.43
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
AURKA O14965 1/20 0.42
AURKB Q96GD4 1/20 0.42
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26628290 1.00 STIM1 (0.75) STIM1ORAI1KEAP1NFE2L2NOTUM
SCHEMBL26628296 0.86 STIM1 (1.00) STIM1ORAI1KEAP1NFE2L2NOTUM
SCHEMBL29946096 0.86 STIM1 (1.00) STIM1ORAI1KEAP1NFE2L2NOTUM
SCHEMBL29946195 0.80 STIM1 (0.88) STIM1ORAI1KEAP1NFE2L2OGT
SCHEMBL26628313 0.80 STIM1 (0.88) STIM1ORAI1KEAP1NFE2L2OGT
SCHEMBL29946187 0.78 STIM1 (0.68) STIM1ORAI1KEAP1NFE2L2NOTUM
SCHEMBL29946184 0.78 STIM1 (0.84) STIM1ORAI1KEAP1NFE2L2HSD17B1
SCHEMBL26628279 0.78 STIM1 (0.68) STIM1ORAI1KEAP1NFE2L2NOTUM
SCHEMBL26628274 0.78 STIM1 (0.84) STIM1ORAI1KEAP1NFE2L2HSD17B1
SCHEMBL29946188 0.77 STIM1 (0.70) STIM1ORAI1NOTUMOGTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4106871-A1 BIPHENYL COMPOUNDS AS SOCE MODULATORS, COMPOSITIONS AND USES THEREOF Università degli Studi del Piemonte Orientale "Amedeo Avogadro" (IT) 2022-12-28 EP claimed
CN-115243765-A Biphenyl compounds as SOCE modulators, compositions and uses thereof 皮埃蒙特阿米阿伏伽德罗东方大学 2022-10-25 CN claimed
EP-4106871-B1 BIPHENYL COMPOUNDS AS SOCE MODULATORS, COMPOSITIONS AND USES THEREOF UNIV DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO (IT) 2024-03-13 EP disclosed
US-20230348404-A1 BIPHENYL COMPOUNDS AS SOCE MODULATORS, COMPOSITIONS AND USES THEREOF UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE "AMEDEO AVOGADRO" (IT) 2023-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348404-A1 BIPHENYL COMPOUNDS AS SOCE MODULATORS, COMPOSITIONS AND USES THEREOF ORAI1, SARAF, STIM1 STIM1 3/4885ORAI1 1/4885KEAP1 1857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.